NTRK fusion testing

NTRK gene fusions can drive unregulated cell growth and proliferation in a range of cancer types. Recently, this pathway gained significant focus and attention in precision oncology.

Next-Generation Sequencing provides the most comprehensive view across a large number of genes and can identify NTRK gene fusions as well as other relevant alterations, with minimal sample tissue needed.

Introduction to NTRK Testing in 3 minutes – Download the Quick Reference guide

• Discover the key factors for NTRK fusion testing
• Compare different testing methods for NTRK fusions
• Learn how to get started with NGS for NTRK testing
• Find the right solution to meet your needs

Complete the form to download the guide

Learn more about Oncomine Solutions

We offer several NGS-based, multibiomarker assays for clinical research designed to simultaneously detect gene fusions, such as NTRK1, NTRK2 and NTRK3, as well as hundreds of DNA and RNA-based genomic alterations associated with cancer. They include: Oncomine Comprehensive Assay, Oncomine Focus Assay, and the Oncomine Childhood Cancer Research Assay.

Explore all Oncomine Solutions

For Research Use Only. Not for use in diagnostic procedures.

NTRK fusion testing